secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001493152-25-011634
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS submits FDA 510(k) AI response; expects clearance decision within six weeks
--------------------------------------------------------------------------------

- Submitted over 1,900 pages including 23 detailed test reports and 7,800 data lines from 10,000 hours of testing.
- New cybersecurity and performance data reinforce fingerprint sweat drug screening platform for U.S. market entry in 2025.
- Company serves 450+ accounts in 24 countries with 18 global distribution partners.
- FDA response anticipated within six weeks.
- CEO calls U.S. market entry a top priority given multi-billion-dollar commercial opportunity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225011634/0001493152-25-011634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225011634/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer